A recent population-based study published in the Journal of American Medical Association identified a modest increase in ...

In smokers with COPD, LABA+LAMA is more effective than LABA+ICS in preventing exacerbations, regardless of blood eosinophil count.

Dupilumab use in asthma linked to higher lymphoma risk, especially T/NK cell types, though overall mortality was lower, new ...

For patients with COPD, long-term inhaled corticosteroid treatment is associated with increased rates of adverse composite and specific individual outcomes.

Trelegy Ellipta, a triple-therapy inhaler containing an inhaled corticosteroid (ICS), a long-acting muscarinic antagonist (LAMA), and a long-acting beta-agonist (LABA), was found to offer ...

This study highlights the benefits of anti-inflammatory inhalers in asthma management, showing reduced complications and modest improvements in symptom control.

Patients prescribed ICS-formoterol, such as Symbicort or Dulera, as a baseline maintenance inhaler were more likely to be prescribed SMART.

Patients prescribed ICS-formoterol, such as Symbicort or Dulera, as a baseline maintenance inhaler were more likely to be prescribed SMART.

Instead, combining SABA with Inhaled Corticosteroids (ICS) is safer and more effective, addressing both immediate symptoms and long-term inflammation, leading to improved asthma management, including ...

The treatment combines fluticasone propionate and albuterol sulfate and is delivered through Teva's breath-activated, multi-dose dry powder inhaler. The drug is currently in late-stage testing.

A generic fluticasone-salmeterol (Wixela Inhub) maintenance inhaler was clinically equivalent to name-brand Advair Diskus for chronic obstructive pulmonary disease (COPD), a propensity score ...